Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant IL2RA (Basiliximab Biosimilar) antibody

This Mouse Chimeric antibody specifically detects IL2RA (Basiliximab Biosimilar) in FACS and ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7093062
$292.43
Plus shipping costs $50.00
Shipping to: United States
Delivery in 12 to 15 Business Days

Quick Overview for Recombinant IL2RA (Basiliximab Biosimilar) antibody (ABIN7093062)

Target

IL2RA (Basiliximab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

  • 6
  • 2
  • 2
Human

Host

  • 2
  • 2
  • 1
  • 1
Mouse

Clonality

  • 5
  • 1
Chimeric

Conjugate

  • 6
This IL2RA (Basiliximab Biosimilar) antibody is un-conjugated

Application

  • 4
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), ELISA

Grade

Research Grade
  • Purpose

    Anti-IL2RA (basiliximab biosimilar) mAb

    Characteristics

    CHI621

    Purification

    Purified from cell culture supernatant by affinity chromatography

    Isotype

    IgG1
  • Application Notes

    ELISA 1:5000-10000, Flow Cyt 1:100

    Comment

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitute with deionized water

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    Expiry Date

    12 months
  • Target

    IL2RA (Basiliximab Biosimilar)

    Target Type

    Biosimilar

    Background

    Synonyms: IL2RA,CD25,p55,IL2-RA,IL-2-RA

    Gene ID

    3559

    UniProt

    P01589
You are here:
Chat with us!